“…Recently, we have focused our attention on donor molecules featuring the simultaneous presence of both N-heterocyclic and chalcogen Lewis donor sites, 18 a ,20 a ,22 c ,25,28 which should enlarge, at least in principle, both the number of products accessible by reaction with di-halogen or interhalogen acceptors and the structural diversity in the resulting self-assembled polyhalide and polyinterhalides architectures. Among the possible donors featuring these structural features, chalcogenophene-fused pyridines represent an interesting class of compounds extensively exploited in medicinal chemistry as promising drugs for the treatment of autoimmune diseases, in materials science as organic semiconductors, and in organic synthesis.…”